Johnson & Johnson Stock Price. Everything You Need To Know About The Johnson & Johnson Stock!
What is Johnson & Johnson Stock Price. Everything You Need To Know About The Johnson & Johnson Stock!?
Johnson & Johnson is a healthcare holding company headquartered in New Brunswick, New Jersey. With 141,700 full-time employees, the firm engages in research and development, manufacture, and sale of products related to human health and well-being. The company operates through three segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment offers personal healthcare products in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health, and wound care markets. The Pharmaceutical segment focuses on six therapeutic areas, including Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism, and Pulmonary Hypertension. The MedTech segment includes interventional solutions, orthopaedics, surgery, and vision fields. The company's shares are traded on major stock exchanges, and its stock price today can be found on financial news websites. Investors can also check the premarket share price before the market opens. Johnson & Johnson's market cap is among the highest in the healthcare industry, and the company's shares are considered a reliable investment by many investors.
Johnson & Johnson Stock Price. Everything You Need To Know About The Johnson & Johnson Stock! performance
How To Invest In Johnson & Johnson Stock From Malaysia, Thailand, Indonesia & Vietnam
Investing in the global market can be a rewarding and profitable venture for retail investors from Malaysia, Thailand, Indonesia, and Vietnam. And when it comes to reliable and stable investment options, one company that stands out is Johnson & Johnson. As a multinational pharmaceutical and consumer goods company, Johnson & Johnson has a strong presence in various segments, including healthcare, personal care, and pharmaceuticals. Its extensive product portfolio and market leadership make it an attractive investment option for those looking for long-term growth and stability. To invest in Johnson & Johnson stock from Malaysia, Thailand, Indonesia, or Vietnam, you can utilize the services of Zorion, an investment platform that provides convenient access to real US stocks, including Johnson & Johnson. With Zorion, you can make informed investment decisions by taking advantage of their comprehensive investment insights and recommendations. Additionally, Zorion offers a wealth of educational resources and materials to further enhance your investment knowledge. Whether you are a novice investor or an experienced one, these resources can provide valuable insights and tips on how to navigate the stock market effectively. Investing in Johnson & Johnson from Malaysia, Thailand, Indonesia, or Vietnam has never been easier. With Zorion's user-friendly platform and expert guidance, you can take advantage of the growth potential and stability that this stock offers. Start your investment journey today and unlock the opportunities that Johnson & Johnson presents.
How To Buy Johnson & Johnson Stock From Malaysia, Thailand, Indonesia & Vietnam
Are you interested in purchasing shares of Johnson & Johnson, one of the most reputable and established companies in the healthcare industry? As a retail investor from Malaysia, Thailand, Indonesia, or Vietnam, you now have the opportunity to invest in this renowned stock through Zorion, the leading investment platform. With its user-friendly interface and extensive investment insights, Zorion enables you to make informed decisions about your investment choices. Whether you're a seasoned investor or just beginning your investment journey, Zorion provides access to a wide range of resources and educational materials to enhance your investment knowledge. Don't miss out on the chance to invest in Johnson & Johnson and potentially reap long-term benefits for your portfolio. Begin your journey with Zorion today.
Johnson & Johnson Analytics and Performance
JNJ: A Company in the LIFE SCIENCES Sector and PHARMACEUTICAL PREPARATIONS Industry
Discover Johnson & Johnson (JNJ), a prominent player in the LIFE SCIENCES sector, specifically within the PHARMACEUTICAL PREPARATIONS industry. As a Common Stock, JNJ has a strong presence not only in the United States but also in various countries around the world, including its home base USA.
JNJ Financial Performance: Key Ratios and Market Indicators
As of the latest quarter ending 2023-09-30, JNJ boasts an EBITDA of 29532998000 and a trailing price-to-earnings ratio (PE ratio) of 29.96. The forward PE ratio stands at 14.62, which indicates stocks potential in earnings. JNJ's price-to-sales ratio (TTM) is 4.404, and the price-to-book ratio is 5.27. The company's enterprise value-to-revenue and enterprise value-to-EBITDA ratios are 4.479 and 17.33, respectively.
JNJ Stock Stability: Analyzing Marketing Volatility and Trends
JNJ stock performance showcases a beta of 0.535, highlighting moderate volatility. The 52-week high and low prices are 173.31 and 143.8, respectively, with a 50-day moving average of 157.46 and a 200-day moving average of 159.76. With 2407280000 shares outstanding, JNJ demonstrates strong performance in the market.
JNJ Dividends: Current Yields and Shareholder Value
In terms of dividends, Johnson & Johnson has a dividend per share of 4.7 and a dividend yield of 0.0306. The company's most recent dividend date was 2024-03-05, and the ex-dividend date was 2024-02-16. JNJ's financials reveal a book value of 29.59 and earnings per share (EPS) of 5.2, with a diluted EPS (TTM) of 5.2.
JNJ Revenue and Profitability: Unveiling the Company's Financial Strength
JNJ revenue per share (TTM) is 33.26, and its total revenue (TTM) amounts to 85159002000. The company's gross profit (TTM) is 63954000000. JNJ's profit margin stands at 0.413, while the operating margin (TTM) is 0.201. The return on assets (TTM) and return on equity (TTM) are 0.101 and 0.18, respectively.
JNJ Growth Prospects: Earnings Growth and Analyst Expectations
JNJ has experienced quarterly earnings growth (YOY) of 0.262, but its quarterly revenue growth (YOY) remains stagnant at -0.097. Analysts have set a target price of 175.05 for Johnson & Johnson stock.
Want To Buy Johnson & Johnson Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: